Wall Street Journal. Europe 2004 jeanne Whalen - Abstracts
| Wall Street Journal. Europe 2004 jeanne Whalen | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Alternative medicine: a big drug maker moves to play down mass-market pills.(Roche Holding Ltd.) | Business, international | Jeanne Whalen | |||
| European drug makers post strong third-quarter results.(pharmaceuticals) | Business, international | Jeanne Whalen | |||
| Glaxo's earnings decline 13%, hit by weak dollar, generics profit expected to rebound in 4th quarter, CEO says as new drugs are released. . | Business, international | Jeanne Whalen, Elena Berton | |||
| Novartis posts 17% profit rise on a 12% increase in revenue. | Business, international | Jeanne Whalen, Anita Greil | |||
| Sanofi-Aventis marriage could spark merger fever. | Business, international | Gautam Naik, Jeanne Whalen | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.